About a month ago I found an article saying the FDA was favorably looking at a new drug called Breo Ellipta. It appears they’ve approved it so it’s just a matter of time before someone you know will be on it. It is important to note this has not been approved for treating asthma. The other big Asthma/COPD players are Advair and Symbicort. I think Dulera has only been approved for Asthma.
The one big difference I noticed about Breo Ellipta is the once a day dosage, similar to Spiriva. Most combo inhalers require twice a day doses and patients often have a hard time following doctor’s orders. I still haven’t seen a picture of what Breo Ellipta looks like, but am guessing I’ll see a poster soon enough in a doctor’s office.
- GlaxoSmithKline and Theravance create new lung drugs (1.000)
- Candy for big kids (0.500)
- CMS50L Pulse Oximeter - Review (0.500)
- The Ides of March (0.500)
- Pari Trek S Portable Aerosol System (0.500)